2010•LeukemiaOpen access

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

Anne Catherine Sprynski, Dirk Hose, Alboukadel Kassambara, Laure Vincent, Michel Jourdan, Jean‐François Rossi, H. Goldschmidt, Bernard Klein

Open full text 90 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 90 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Insulin receptor, Insulin, Insulin-like growth factor, Receptor, Endocrinology, Insulin-like growth factor 1 receptor, Internal medicine, Insulin receptor substrate

Back to paper search Browse research topics Original source

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation — Research Paper | ScholarLens